Administrative Core

行政核心

基本信息

  • 批准号:
    10673113
  • 负责人:
  • 金额:
    $ 9.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

The Administrative Core will provide the governance and coordination structure to spearhead the Atlas generation in the JMN-MSMP. The Administrative Core will coordinate and integrate the Biological Analysis Core (BAC) and Data Analysis Core (DAC), and will ensure harmonization of processes and quality control within the JMN-MSMP and with the SenNet Consortium Organization and Data Coordination Center (CODCC) to provide standardized, high-quality datasets for Atlas generation. The MPIs will engage all key stakeholders in shared governance to ensure that perspectives from all components are considered. This will be achieved through an Executive Committee (EC) consisting of the MPIs, and Core Leaders. The AC will coordinate monthly meetings of the EC to review operations, benchmarks, and metrics for continuous quality improvement; provide a forum to introduce emerging opportunities of interest; and formulate action plans for a coordinated response. Internal and External Advisory Committees will provide regular, expert, arms-length advice on scientific decisions, review progress, and assist with conflict resolution. The Administrative Core will work closely with the NIH program manager and external TMCs and data coordinating centers to communicate processes and datasets. Aim 1. Provide JMN-MSMP interdisciplinary leadership and governance structure. Aim 2. Oversee and Coordinate the Biological Analysis and Data Analysis Cores. Aim 3. Coordinate with other SenNet sites to standardize operations and protocols; and prepare, organize, and maintain JMN-MSMP reports and Atlas development.
行政核心将提供领导的治理和协调结构

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JENNIFER H ELISSEEFF其他文献

JENNIFER H ELISSEEFF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JENNIFER H ELISSEEFF', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10556889
  • 财政年份:
    2022
  • 资助金额:
    $ 9.16万
  • 项目类别:
Single cell characterization of the biomaterial immune and stromal response
生物材料免疫和基质反应的单细胞表征
  • 批准号:
    10230987
  • 财政年份:
    2020
  • 资助金额:
    $ 9.16万
  • 项目类别:
Single cell characterization of the biomaterial immune and stromal response
生物材料免疫和基质反应的单细胞表征
  • 批准号:
    10431933
  • 财政年份:
    2020
  • 资助金额:
    $ 9.16万
  • 项目类别:
Single cell characterization of the biomaterial immune and stromal response
生物材料免疫和基质反应的单细胞表征
  • 批准号:
    10617307
  • 财政年份:
    2020
  • 资助金额:
    $ 9.16万
  • 项目类别:
Biomaterials-directed regenerative immunotherapies
生物材料导向的再生免疫疗法
  • 批准号:
    10697362
  • 财政年份:
    2019
  • 资助金额:
    $ 9.16万
  • 项目类别:
Biomaterials-directed regenerative immunotherapies
生物材料导向的再生免疫疗法
  • 批准号:
    10023168
  • 财政年份:
    2019
  • 资助金额:
    $ 9.16万
  • 项目类别:
Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics
开发针对嵌合体的 BCL-xL 蛋白水解作为更安全、更好的 senolytics
  • 批准号:
    10375406
  • 财政年份:
    2019
  • 资助金额:
    $ 9.16万
  • 项目类别:
Biomaterials-directed regenerative immunotherapies
生物材料导向的再生免疫疗法
  • 批准号:
    10251325
  • 财政年份:
    2019
  • 资助金额:
    $ 9.16万
  • 项目类别:
Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics
开发针对嵌合体的 BCL-xL 蛋白水解作为更安全、更好的 senolytics
  • 批准号:
    10599230
  • 财政年份:
    2019
  • 资助金额:
    $ 9.16万
  • 项目类别:
Statistical optimization of self-assembled biosynthetic cornea implants
自组装生物合成角膜植入物的统计优化
  • 批准号:
    9913555
  • 财政年份:
    2018
  • 资助金额:
    $ 9.16万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 9.16万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 9.16万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 9.16万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 9.16万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 9.16万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 9.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了